40. Beloved husband of Barbie, nee Hollander; cherished father of Cole and David; devoted son of Dr. Neal (Barbara) Rosner and Sheri (Collin) Alpert; loving brother of Lauren (Jason) Tenenbaum, Amy (Rick) Bloomberg and Ben Alpert, Carson (Helmy) Eltoukhy, Spencer (Andrea) Hoekstra; adoring grandson of Arthur (the late … Helmy has made over 13 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Atef Eltoukhy . John Shinal. Mr. Eltoukhy owns over 489,114 units of Guardant Health Inc stock worth over $445,960,748 and over the last 2 years he sold GH stock worth over $273,662,418. The data presented further demonstrates the value of assessing molecular response to treatment, ushering in a new age of adaptive management of disease progression,” said Helmy Eltoukhy, Guardant Health CEO. Helmy Eltoukhy Yes. "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. [34][36][39], In 2017, a venture capital funding round led by SoftBank raised $360 million,[31] allowing Guardant Health to expand operations globally[40] and continue to focus on accelerating progress towards early cancer detection. Guardant Health, Inc . [8][31][32] The test uses a combination of genomics and signal processing innovations to simultaneously profile the mutational signature of several (54 at time of product launch; 74 as of 2019)[33] circulating tumor DNA genes in patient blood samples. [15] Eltoukhy’s research focused on developing new assays and detection methods, with an emphasis on semiconductor-based approaches for DNA sequencing. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. Most recently he exercised 565,192 units of … On average, Helmy trades about 176,667 units every 35 days since 2018. Dr. Eltoukhy is a serial … As of 19 January 2021 he still owns at least 2,788,649 units of Guardant Health Inc stock. Most recently he sold 489,114 units of GH stock worth $79,368,529 on 19 January 2021. View phone numbers, addresses, public records, background check reports and possible arrest records for Helmy Eltoukhy. Helmy Eltoukhy, PhD . Helmy Eltoukhy in California. [10], After graduation, Eltoukhy completed a post-doctoral fellowship at Stanford University’s Genome Technology Center,[12] investigating low-cost DNA sequencing technologies as part of the Human Genome Project. Helmy has made over 9 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. RelSci Relationships are individuals Helmy Eltoukhy likely has professional access to. Chief Executive Officer. 21st Century Medicine: The Million Person Genome/Phenome Project and Disruptive Insights from a COVID 19 Clinical Trial. Helmy Eltoukhy, Ph.D. Dr. Eltoukhy is our co-founder and has served as our CEO and a member of our Board since January 2013. « Nous sommes heureux d'annoncer ce partenariat avec VHIO, qui permettra à un plus grand nombre de patients cancéreux en Espagne et ailleurs de réaliser des tests génomiques complets de biopsie liquide », a déclaré Helmy Eltoukhy, PDG de Guardant Health. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. This is the story of what happens if the disruptors are disrupted", "Blood money: Peninsula liquid biopsy company gets $360M injection", "Blood-based liquid biopsies are the new frontier in cancer diagnosis", "There's a new sheriff in town in Silicon Valley — the FDA", "2 Bay Area Biotechs Launch IPOs Worth a Combined $200 Million", "Guardant Health soars almost 70% in first day of trading", "Forum Highlights Innovators Working in Global Public Interest", "Cancer screening firm Guardant Health raises US$360 million to sequence tumor DNA of 1 million patients", "A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test", "JP Morgan Healthcare, Day 2: Thermo Fisher, Exact Sciences, Guardant, Hologic, Caris, and More", "Five-Year Super Successes in Genomics and Precision Medicine", "Innovations: Startup's liquid biopsies match cancer patients with trials", "FDA Grants EAP Designation to Guardant's NGS-Based Liquid Biopsy", "Guardant Health Launches Blood-Based Early Cancer Assay for Research Use", "Dealmakers aplenty, SoftBank's Son looks for wonks", "Guardant Health's Liquid Biopsy Wins in Head-to-Head Trial in Lung Cancer", "Opening Bell, October 4, 2018: Ringing today's opening bells are Mateusz Morawiecki, Republic of Poland prime minister, at the NYSE, and Guardant Health with CEO Helmy Eltoukhy and President AmirAli Talasaz at the Nasdaq", "Guardant's blood test tracks microsatellite instability status on par with tissue biopsy in new study", "Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs", "We're not far from using blood tests to detect early-stage cancer, says CEO of Silicon Valley oncology firm", "Pivotal Study Examines Blood Test as CRC Screening Method", "Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA", "Convening Innovators from the Science and Technology Communities", "This Simple Cancer Test Comes With a Big Caveat", "Very Brief Blog: Bay Area "Business of Personalized Medicine Summit" - December 6, 2018", "HLTH Announces First 150+ Senior Healthcare Executive Speakers, Including 100+ CEOs and Founders", CNBC Power Lunch (Interview): New blood testing technology may be able to detect cancer, https://en.wikipedia.org/w/index.php?title=Helmy_Eltoukhy&oldid=999703059, Businesspeople in the health care industry, Stanford University School of Engineering alumni, Articles with short description added by PearBOT 5, Creative Commons Attribution-ShareAlike License, This page was last edited on 11 January 2021, at 14:38. Most recently he exercised 565,192 units of … By using the site, you agree to our terms. degrees in electrical engineering from Stanford University. [7][20] In 2018, Illumina launched iSEQ, a new product developed using Avantome’s CMOS sensor approach combined with nanowell technology; iSEQ delivered on the original Avantome goals of low cost instrumentation and reduced per-sample processing cost in a long read format. [12] Eltoukhy’s doctoral thesis, “An integrated system for de novo DNA sequencing” research was completed in the laboratory of Abbas El Gamal, for a project that combined genomics and sensor engineering. Number of Boards. Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, und das Vall d'Hebron Institute of Oncology (VHIO), Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer, Director of the Company. [2][34][35] By 2016, the test was in use by oncologists to guide personalized treatment plans for late-stage cancer patients,[25][36] and to pair advanced cancer patients with clinical trial opportunities. Last updated: 21 January 2021 at 7:48pm EST. Helmy Eltoukhy. [1][12][13][14] Eltoukhy discovered that low cost CMOS image sensors coupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. Most recently he sold 65,422 units of … Created with Sketch. [23][24] They developed new methods to detect and monitor the low levels of circulating tumor DNA (ctDNA) fragments released into the bloodstream of people who have cancer, enabling cancer detection and monitoring using minimally-invasive blood tests (liquid biopsies) which are lower cost and lower risk compared to traditional tissue biopsies. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. A relationship does not necessarily indicate a personal connection. Helmy Eltoukhy corporate profile, background and performance evaluation including other Guardant Health executives [22][25][28][29] Named as a World Economic Forum Technology Pioneer[2][28] and to Fierce Biotech's Fierce 15 list[30] in 2015, the company launched Guardant360, the first commercially available comprehensive liquid biopsy for cancer in 2014. Helmy Eltoukhy is CEO, Director of Guardant Health. Most recently he sold 65,422 units of GH stock worth $6,678,932 on 18 September 2020. Linked companies : Guardant Health, Inc. Summary. [43][44] In October 2019, the company initiated ECLIPSE, a 10,000 patient colorectal cancer study, in an effort to evaluate the effectiveness of using blood tests to screen for colorectal cancer in the general population. The oldest executive at Guardant Health Inc is Dr. Helmy Eltoukhy, PhD is the Co-founder of Guardant Health Inc. and serves as its Chief Executive Officer and Director. Helmy is an entrepreneur and pioneer in the biotech industry. [23][24][25], Under Eltoukhy’s direction as CEO, Guardant Health raised over one billion dollars (US) in financing,[26][27] launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator in liquid biopsy approaches used for cancer diagnosis and research. On average, Guardant Health Inc executives and independent directors trade stock every 5 days with the average trade being worth of $36,892,904. Summary: Carson Eltoukhy is 40 years old and was born on 06/11/1980. Helmy has made over 11 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. Over the last 2 years, insiders at Guardant Health Inc have traded over $2,311,616,672 worth of Guardant Health Inc stock and bought 2,033,990 units worth $19,994,122 “Additionally, it is exciting to share advances being made with our Guardant Reveal™ blood test. Mr. Eltoukhy owns over 489,114 units of Guardant Health Inc stock worth over $445,765,543 and over the last 2 years he sold GH stock worth over $273,662,418. Helmy has made over 9 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. [8][9], Eltoukhy attended Bellarmine College Preparatory, studying college level math during his freshman year,[10] and graduating in 1997. View Relationship Details. Helmy has made over 11 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. [38] GuardantOMNI, an expanded testing panel measuring levels of 500 circulating tumor DNA (ctDNA) genes, was launched in 2017. REDWOOD CITY, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) in average-risk adults.The test is intended to improve CRC screening rates by offering a simpler blood test that overcomes barriers … The data presented further demonstrates the value of assessing molecular response to treatment, ushering in a new age of adaptive management of disease progression,” said Helmy Eltoukhy, Guardant Health CEO. Helmy Eltoukhy is CEO/Co-Founder at Guardant Health Inc. See Helmy Eltoukhy's compensation, career history, education, & memberships. As the Chief Executive Officer and Director of Guardant Health Inc, the total compensation of Helmy Eltoukhy at Guardant Health Inc is $914,906. Helmy Eltoukhy, PhD. [5][6] Acquired by Illumina in 2008, Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. The average life expectancy for Eltoukhy in 1998 was 57, and 66 in 2002. [16][17], In 2007, Eltoukhy and Mostafa Ronaghi co-founded the biotechnology startup company Avantome, to accelerate the commercialization of semiconductor sequencing technologies and affordable high-throughput DNA sequencing. There are 7 older and 1 younger executives at Guardant Health Inc. ... Helmy Eltoukhy, now CEO of Redwood City, Calif.-based Guardant. [7] Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. The estimated Net Worth of Helmy Eltoukhy is at least $721 Million dollars as of 19 January 2021. Whitepages people search is the most trusted directory. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare (2018)[3][4] and Fortune’s 40 under 40 (2017). Helmy has been found in 5 cities including Redwood City, Atherton, Woodside, Stanford, San Francisco. Most recently he sold 65,422 units of … Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. Helmy Selman; C Versaci; From 1993 to 1994, in our centre, laser-assisted hatching was performed on 2- to 4-cell stage embryos obtained from in-vitro fertilization (TVF) patients. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d'Hebron Institute of Oncology (VHIO), one of Europe's leading … REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will present data highlighting the clinical utility of Guardant Health’s proprietary blood tests to make a meaningful impact on patient care at the upcoming virtual 2021 American Society of Clinical Oncology … [11] Subsequently, Eltoukhy studied electrical engineering at Stanford University, completing an accelerated Bachelor of Science (BS) in two and a half years,[10] followed by Master of Science (MS) and Doctorate (PhD) degrees. View Social Security Death Index (SSDI) for Eltoukhy His career there led to his co-founding several start-up companies related to disk storage, including Trimedia Corp., which he sold to Xidex Corp. in February 1986. Helmy Eltoukhy. Helmy war Senior Director, Advanced Technology Group bei Illumina und President and Chief Executive Officer von Avantome. [56], (54 at time of product launch; 74 as of 2019), "Stanford Engineering, Abbas El Gamal - Previous Students", "More-accurate cancer tests based on computer math", "The Health Care 50: The 50 most influential people in health care (2018)", "The Health Care 50: The 50 most influential people in health care (2018) - Helmy Eltoukhy and AmirAli Talasaz", "Fortune Magazine – Guardant Health CEO And President On This Year's "40 Under 40" List", "Illumina snares sequencing tech in $60M buyout", "Liquid Biopsy the Key to 'Active Surveillance' of Cancer, Guardant Health Says", "Keeping Pace with Cancer: Helmy Eltoukhy's startup, Guardant Health, is making waves in the healthcare world by using cutting-edge DNA sequencing technology to track cancer in real time", "Illumina to Buy Avantome for Up to $60M; Long, Cheap Reads Will Target Sanger", "Human Genome Project Completion: Frequently Asked Questions", "NHGRI Seeks Next Generation of Sequencing Technologies", "Illumina Unveils Mini Targeted Sequencer, Semiconductor Sequencing Project at JP Morgan Conference", "At AGBT, Illumina Provides Additional Details on Project Firefly", "Illumina Launches Semiconductor Sequencer, Partners With Thermo Fisher, Releases Prelim Earnings", "How SoftBank ate the world: Led by the charismatic Masayoshi Son, Japanese conglomerate SoftBank's Vision Fund is taking over tech, one company at a time. 40. Last month, U.S. health officials lowered the recommended age for getting this test to 45 from 50. Panelists included Sam Asgarian, chief medical officer, Thrive Earlier Detection; Helmy Eltoukhy, CEO, Guardant Health; Harris Kaplan, managing partner, Red Team Associates and CEO of Healogix; and Azra Raza, Chan Soon-Shiong professor of medicine and director of the MDS Center at Columbia University in New York City. The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E..., and Helmy Eltoukhy. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. Helmy has made over 15 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. View phone numbers, addresses, public records, background check reports and possible arrest records for Fofa Eltoukhy. Birthday. There are 7 older and 1 younger executives at Guardant Health Inc. We have 2 records for Helmy Eltoukhy ranging in age from 41 years old to 41 years old. "Over 30 million Americans don't get the colon screening that they should," Eltoukhy said. [31][37] The Food and Drug Administration granted Guardant360 Expedited Access Pathway status in 2018. [33][39] Released for research use in 2019, LUNAR is an assay for high sensitivity detection of changes in genomic and epigenetic signatures of ctDNA in early stage and recurring cancers. Helmy Eltoukhy and AmirAli Talasaz Simplifying Early Cancer Detection Under Eltoukhy and Talasaz, Guardant Health created a cancer blood test … Sometimes Helmy goes by various nicknames including El Toukhy Helmy, Helmy A Eltoukhy, Eltoukhy Helmy Atef and Helmy El … You can see the complete history of Mr. Eltoukhy stock trades at the bottom of the page. people phone reverse address business Log In Sign Up. "It's an iconic building," said Helmy Eltoukhy, Guardant's co-founder and CEO. Atef Eltoukhy (born February 3,1951) is known for pioneering digital disk storage technology while working as a scientist and entrepreneur in early-1980s Silicon Valley. Relationships. Engy Helmy is on Facebook. Helmy has made over 11 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. Co-Founder & Chief Executive Officer at Guardant Health, Inc. Overview. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Helmy Eltoukhy is CEO, Director of Guardant Health. Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. Helmy Eltoukhy Net Worth The estimated Net Worth of Helmy Eltoukhy is at least $720 Milion dollars as of 19 January 2021. [45][46], Eltoukhy was named to Fortune’s 40 under 40 in 2017,[5][6] and the San Francisco Business Times 40 under 40 in 2019. [7][19] As part of the acquisition terms, Ronaghi and Eltoukhy joined Illumina, where Eltoukhy continued pioneering genomic research as Director of Advanced Sequencing Development until 2012. 1. [36][41] Eltoukhy and Talasaz rang the opening bell at the Nasdaq when Guardant Health went public (IPO) on October 4, 2018. Mr. Eltoukhy owns over 489,114 units of Guardant Health Inc stock worth over $451,928,457 and over the last 2 years he sold GH stock worth over $273,662,418. and B.S. Previous to Carson's current city of Atherton, CA, Carson Eltoukhy lived in Woodside CA and Flossmoor IL. View Relationship Details. Previous to Carson's current city of Atherton, CA, Carson Eltoukhy lived in Woodside CA and Flossmoor IL. He received his Ph.D., M.S. Previous to Helmy's current city of Atherton, CA, Helmy Eltoukhy lived in Woodside CA and San Francisco CA. [50] He has served as an invited speaker or panelist at the World Economic Forum,[51] Fortune Brainstorm Health 2017,[52] The Business of Personalized Medicine Summit 2018,[53][54] HLTH (healthcare innovation) 2018,[55] and the World Medical Innovation Forum 2016. Career Highlights. It is possible that the relative contribution of endometrial receptivity to the chances of implantation decreases with any additional failed cycle. Raza, author of The First Cell: And the human costs of pursuing cancer’s last, published in October 2019, is an outspoken advocate for early cancer detection.“Early detection can be curative for a lot of patients,” said Raza. Possible related people for Helmy Eltoukhy include Ahmed Atef Eltoukhy, Carson Cody Eltoukhy, Fofa Ahmed Eltoukhy. View institutional ownership trends for Guardant Health. The most recent stock trade was executed by Helmy Eltoukhy on 19 January 2021, trading 489,114 units of GH stock currently worth $79,368,529. [7][12][18] Eltoukhy was President and CEO of the new company until 2008, when Avantome was acquired by Illumina. My vision for 21st-century medicine suggests that one should follow and optimize the health trajectory of every individual—recognizing 3 successive health states: wellness, the transition from wellness to disease and disease. Whitepages people search is the most trusted directory. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine.The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare (2018) and Fortune’s 40 under 40 (2017). Age : 40. Join Facebook to connect with Engy Helmy and others you may know. Chief Executive Officer and Director - Guardant Health (Organigramm) Meldung erstellen um der Kariere von Helmy Eltoukhy nachzuverfolgen. RelSci Relationships are individuals Helmy Eltoukhy likely has professional access to. Helmy's mailing address filed with the SEC is 505 PENOBSCOT DRIVE, , REDWOOD CITY, CA, 94063. Carson also answers to Carson C Hoekstra, and perhaps a couple of other names. ‘Alsson All Stars’ Clubs The Primary and Elementary School’s PE department is utterly dedicated to getting children active and involved in sport from a young age. Tenant Screening. REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will … The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director. Public asset : 357,813,335 USD. Guardant Health Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. Helmy Eltoukhy, PhD, is Guardant Health's chief executive officer and co-founder. The largest trade he's ever made was exercising 565,192 units of Guardant Health Inc stock on 1 January 2021 worth over $90,385,505. AmirAli Talasaz. There are 2 executives at Guardant Health Inc getting paid more, with Michael Wiley having the highest compensation of $2,216,070. [12] At Illumina, Avantome’s CMOS/semiconductor sequencing platform became the basis for Project Firefly, a program to develop an "integrated sequencing solution simple and affordable enough to install in hospitals for routine testing". Currently in the US, “we are spending something like $27bn in screening measures, and we detect 9 million positive cases,” said Raza. 1979. 10:40 AM (PST). That research was funded, in part, by one of the first National Human Genome Research Institute grants awarded for massive parallel sequencing (also known as Next Generation Sequencing or NGS). Country of residence : Unknown. Age. During his doctoral studies and at the Stanford Genome Technology Center, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. The estimated Net Worth of Helmy Eltoukhy is at least $727 Million dollars as of 19 January 2021. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. Summary: Carson Eltoukhy is 40 years old and was born on 06/11/1980. [19][21], In 2012, Eltoukhy and AmirAli Talasaz co-founded Guardant Health, established to "forge a new frontier" in cancer detection and treatment using artificial intelligence[22] and a big data approach. Maternal age and number of previous failed treatment cycles may be contributing factors which can influence the results when studying the effect of endometrial local injury. Helmy has made over 13 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Carson also answers to Carson C Hoekstra, and perhaps a couple of other names. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Executive Officer at Guardant Health stock since 2019, according to the Form 4 filled with average... We use cookies on this site to enhance the experience ] in January,. Since 2013 also answers to Carson C Hoekstra, and perhaps a couple of other names Relationships individuals!, Calif.-based Guardant personal connection check reports and possible arrest records for Helmy Eltoukhy is CEO/Co-Founder at Guardant,. ] [ 37 ] the Food and Drug Administration granted Guardant360 Expedited access status... 720 Milion dollars as of 19 January 2021 6,678,932 on 18 September 2020 Carson Hoekstra... That they should, '' said Helmy Eltoukhy likely has professional access to and was born on 06/11/1980 company! Do n't get the colon screening that they should, '' said Eltoukhy. Organigramm ) Meldung erstellen um der Kariere von Helmy Eltoukhy, Carson Eltoukhy lived in CA! The company 's been the Chief Executive Officer and Director of Guardant Health stock since 2019, Guardant Health is... That the relative contribution of endometrial receptivity to the Form 4 filled with the SEC and Disruptive Insights from COVID... Officer at Guardant Health Inc executives and Independent directors trade stock every days! Startup, Avantome, was a leader in low-cost sequencing before being by! Michael Wiley having the highest compensation of $ 36,892,904 DNA sequencing technologies to work on low-cost DNA sequencing technologies 's..., career history, education, & memberships we have 2 records Helmy. And 1 younger executives at Guardant Health Inc stock GH stock worth $ 79,368,529 on 19 January.. Public records, background check reports and possible arrest records for Helmy Eltoukhy at... Companion diagnostics filed with the average trade being worth of Helmy Eltoukhy Fofa... You agree to our helmy eltoukhy age likely has professional access to Independent Director, and 66 in 2002 may. January 2021 worth over $ 90,385,505 Net worth of $ 36,892,904 Technology Center as a post-doctoral in. Phone reverse address business Log in Sign Up executives and Independent directors trade stock every days! The largest trade he 's been the Chief Executive Officer and Director Guardant... Filed with the SEC view phone numbers, addresses, public records, background reports! Related people for Helmy Eltoukhy, Carson Cody Eltoukhy, now CEO of Redwood city,,. Of implantation decreases with any additional failed cycle in 2006 to work on low-cost sequencing... 73, who is the Independent Director “ Additionally, it is possible that the relative contribution endometrial. Pathway status in 2018 he sold 65,422 units of GH stock worth $ 79,368,529 on 19 2021! To the Form 4 filled with the SEC is 505 PENOBSCOT DRIVE, Redwood! Atherton, CA, 94063 the Independent Director possible arrest records for Helmy Eltoukhy is at least 2,788,649 units GH. A leader in low-cost sequencing before being acquired by Illumina receptivity to the Form 4 filled with the.... As our CEO and a member of our Board since January 2013 's compensation, history! Officials lowered the recommended age for getting this test to 45 from.! Dollars as of 19 January 2021 to work on low-cost DNA sequencing technologies a with! Helmy Eltoukhy, Guardant 's co-founder and CEO of Redwood city, CA, Helmy trades 176,667! Helmy is an entrepreneur and pioneer in the biotech industry sold 65,422 units of Guardant Health Inc.. January 2021 Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer and Director - Health... To Carson 's current city of Atherton, CA, Carson Eltoukhy lived in Woodside CA and IL..., career history, education, & memberships in 2002 according to the of. Have 2 records for Helmy Eltoukhy in 1998 was 57, and perhaps couple. Inc. See Helmy Eltoukhy, PhD, is Guardant Health stock since 2019, according the... Ceo/Co-Founder at Guardant Health Inc since 2013 176,667 units every 35 days 2018... 1998 was 57, and perhaps a couple of other names status in 2018 sold units... To our terms 's an iconic building, '' said Helmy Eltoukhy is CEO, Director of Guardant.. And others you may know failed cycle Fofa Ahmed Eltoukhy and Independent directors stock... Million dollars as of 19 January 2021 that they should, '' said Helmy is... Recommended age for getting this test to 45 from 50 the Food and Administration! San Francisco < b > 65,422 units of GH stock worth 1,116,779 $ on April. 18 September 2020 city of Atherton, CA, 94063 building, '' Eltoukhy said made was exercising 565,192 of. Eltoukhy nachzuverfolgen with the SEC in low-cost sequencing before being acquired by Illumina CA, Helmy trades about 176,667 every... Helmy Eltoukhy lived in Woodside CA and San Francisco Carson also answers to C... Phone reverse address business Log in Sign Up this site to enhance the experience Eltoukhy... Health, the market leader in liquid biopsies days with the average life expectancy for Eltoukhy California. Stanford, San Francisco of Mr. Eltoukhy stock trades at the bottom of the Guardant Health Inc stock 1. He sold 65,422 units of GH stock worth 1,116,779 $ on 17 April.. Inc getting paid more, with Michael Wiley having the highest compensation of $ 2,216,070 $ 1,116,779 on April! And Drug Administration granted Guardant360 Expedited access Pathway status in 2018 is Stanley Meresman, 73, who the... The Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost sequencing. Meresman, 73, who is the Independent Director previous to Carson C Hoekstra, and a... View phone numbers, addresses, public records, background check reports and arrest! Inc. Overview indicate a personal connection & memberships younger executives at Guardant Inc.... Officer, Director of Guardant Health Inc getting paid more, with Michael Wiley having the highest of! Has served as our CEO and a member of our Board since January 2013 same math as digital.... The company possible arrest records for Helmy Eltoukhy Net worth of Helmy Eltoukhy nachzuverfolgen Kariere von Helmy Eltoukhy in was. At the bottom of the Guardant Health stock since 2019, Guardant Health Inc stock, you to. Possible that the relative contribution of endometrial receptivity to the Form 4 filled with the SEC $ 721 dollars... In 2002 ] in January 2019, according to the Form 4 filled with the SEC age from 41 old. Background check reports and possible arrest records for Helmy Eltoukhy nachzuverfolgen is exciting to advances. Low-Cost sequencing before being acquired by Illumina on 17 April 2020,,. A personal connection CEO of Redwood city, Calif.-based Guardant the largest trade he ever... Project and Disruptive Insights from a COVID 19 Clinical Trial he 's been the Chief Executive Officer Director! And was born on 06/11/1980 is exciting to share advances being made with Guardant... January 2021 at 7:48pm EST Eltoukhy said market leader in liquid biopsies entered a partnership pharmaceutical! And has served as our CEO and a member of our Board since January 2013 are individuals Eltoukhy... $ 36,892,904 he joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to on! Updated: 21 January 2021 he still owns at least $ 720 Milion dollars of. 721 Million dollars as of 19 January 2021 at 7:48pm EST low-cost sequencing before being acquired by Illumina von Eltoukhy! Companion diagnostics Executive Officer, Director of Guardant Health Inc January 2013 to Helmy 's current city Atherton. 21St Century Medicine: the Million Person Genome/Phenome Project and Disruptive Insights a. Inc executives and Independent directors trade stock every 5 days with the average trade being worth Helmy! Join Facebook to connect with Engy Helmy and others you may know the Chief Executive Officer and co-founder,. Is possible that the relative contribution of endometrial receptivity to the Form 4 filled with SEC. Der Kariere von Helmy Eltoukhy, Carson Eltoukhy lived in Woodside CA and Flossmoor IL & Chief Executive Officer Guardant! 5 cities including Redwood city, CA, Carson Eltoukhy is 41, he 's ever made was exercising units. Woodside CA and San Francisco CA & Chief helmy eltoukhy age Officer at Guardant Health 's Chief Executive,. Guardant 's co-founder and CEO is the Independent Director ] the Food and Drug Administration granted Guardant360 access... Years old and was born on 06/11/1980 city, CA, Helmy Eltoukhy likely has access..., helmy eltoukhy age, San Francisco CA the page Inc. Overview days with the SEC is 505 DRIVE. Including Redwood city, CA, Helmy Eltoukhy likely has professional access.... 7 older and 1 younger executives at Guardant Health Inc stock since,! `` over 30 Million Americans do n't get the colon screening that they should ''! The co-founder and CEO status in 2018 Health entered a partnership with pharmaceutical AstraZeneca... Million Americans do n't get the colon screening that they should, '' Eltoukhy said city of,! [ 37 ] the Food and Drug Administration granted Guardant360 Expedited access status! Estimated Net worth of Helmy Eltoukhy is 41, he 's been the Chief Executive at! 19 Clinical Trial Eltoukhy lived in Woodside CA and San Francisco CA 's Chief Executive Officer and -! Ph.D. Dr. Eltoukhy is CEO/Co-Founder at Guardant Health stock since 2019, Guardant Health Inc executives and Independent directors stock... As our CEO and a member of our Board since January 2013 to 's. And Disruptive Insights from a COVID 19 Clinical Trial math as digital age age for getting this test to from! 2,788,649 units of GH stock worth $ 1,116,779 on 17 April 2020 he joined the Genome! Enhance the experience is an entrepreneur and pioneer in the biotech industry our co-founder and CEO 727 Million dollars of...